AN ECONOMIC PRICE ANALYSIS OF CONVENTIONAL REMISSION THERAPY VS BIOLOGICAL THERAPY FOR RHEUMATOID ARTHRITIS TREATMENT

Rheumatoid arthritis represents the most common inflammatory rheumatism, affecting about 1% of the general population. Inappropriately untreated usually has a progressively aggressive perspective, generating pain and joint inflammation and functional disability. The severity of the disease resul...

Full description

Bibliographic Details
Published in:	Management & Marketing
Main Authors:	Mihaela-Simona SUBTIRELU, Adina TURCU-STIOLICA, Florentin-Ananu VREJU, Johny NEAMTU
Format:	Article
Language:	English
Published:	Universitaria Press Craiova 2019-05-01
Subjects:	biological therapy access analysis conventional remission rheumatoid arthritis
Online Access:	http://mnmk.ro/en/documents/2019_1/3-10-2-19.pdf

Similar Items

THE STUDY ON THE MEDICAL ADHERENCE OF PATIENTS TO RHEUMATOID ARTHRITIS TREATMENT
by: Mihaela-Simona SUBTIRELU, et al.
Published: (2018-05-01)

RHEUMATOID ARTHRITIS: THE PROBLEMS OF REMISSION AND THERAPY RESISTANCE
by: E. L. Nasonov, et al.
Published: (2018-07-01)

Intensive therapy and remissions in rheumatoid arthritis: a systematic review
by: Catherine D. Hughes, et al.
Published: (2018-10-01)

Demographics and clinical characteristics associated with sustained remission and continuation of sustained remission in patients with rheumatoid arthritis treated with adalimumab
by: Noriko Kimura, et al.
Published: (2019-03-01)

The Influence of Socio-Demographic Factors, Lifestyle and Psychiatric Indicators on Adherence to Treatment of Patients with Rheumatoid Arthritis: A Cross-Sectional Study
by: Adina Turcu-Stiolica, et al.
Published: (2020-04-01)

ADALIMUMAB DISCONTINUATION IN PATIENTS WITH RHEUMATOID ARTHRITIS AFTER ACHIEVING SUSTAINED REMISSION
by: N. V. Demidova, et al.
Published: (2018-07-01)

Are the goals of therapy achievable in patients with rheumatoid arthritis receiving upadacitinib in real clinical practice?
by: V. N. Amirjanova, et al.
Published: (2022-07-01)

Cytokine Signatures as Biomarkers of Clinical Remission in Rheumatoid Arthritis
by: Su W, et al.
Published: (2025-06-01)

Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial
by: Josef S. Smolen, et al.
Published: (2018-01-01)

EVALUATION OF ULTRASOUND REMISSION CRITERIA IN PATIENTS WITH RHEUMATOID ARTHRITIS DURING TOCILIZUMAB THERAPY
by: Rita Aleksandrovna Osipyants, et al.
Published: (2013-12-01)

Disease remission and sustained remission after etanercept biosimilar or originator initiation in rheumatoid arthritis: an interim real-world analysis
by: Marina G. Birck, et al.
Published: (2025-07-01)

Optical imaging (HandScan) can identify ultrasound remission in rheumatoid arthritis
by: Charline Rinkin, et al.
Published: (2024-05-01)

Dual antibody status predicts sustained remission in patients with rheumatoid arthritis
by: Praveen Pratap Jadhav, et al.
Published: (2019-01-01)

The long-term remission of rheumatoid arthritis with a single cycle of rituximab
by: Glišić Branislava, et al.
Published: (2012-01-01)

Sustained remission of rheumatoid arthritis following COVID-19 vaccination
by: Angelo Nigro
Published: (2025-06-01)

The application value of MRI in the diagnosis of subclinical inflammation in patients with rheumatoid arthritis in remission
by: Huimei Zhang, et al.
Published: (2018-07-01)

The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis
by: Yoshiya Tanaka, et al.
Published: (2019-07-01)

STRATEGY FOR DOSE REDUCTION AND DISCONTINUATION OF BIOLOGICAL AGENTS IN RHEUMATOID ARTHRITIS REMISSION
by: M. A. Kotovskaya, et al.
Published: (2018-03-01)

PDCD5 as a Potential Biomarker for Improved Prediction of the Incidence and Remission for Patients with Rheumatoid Arthritis
by: Juan Xiao, et al.
Published: (2023-08-01)

Transitional and CD21− PD-1+ B cells are associated with remission in early rheumatoid arthritis
by: Sarah McGrath, et al.
Published: (2025-04-01)

Clinical, Imaging, and Pathological Suppression of Synovitis in Rheumatoid Arthritis: Is the Disease Curable?
by: Serena Bugatti, et al.
Published: (2018-05-01)

Association Between Patient-Reported Pain and Remission or Low Disease Activity in Patients with Rheumatoid Arthritis: Data from RA-BE-REAL Prospective Observational Study
by: Peter C. Taylor, et al.
Published: (2024-12-01)

Putative Association between Low Baseline Gene Expression in the Peripheral Blood and Clinical Remission in Rheumatoid Arthritis Patients Treated with Tofacitinib
by: Elena V. Tchetina, et al.
Published: (2021-12-01)

Ten-year radiographic and functional outcomes in rheumatoid arthritis patients in remission compared to patients in low disease activity
by: Adeline Ruyssen-Witrand, et al.
Published: (2023-10-01)

Prevalence and predictors of sustained remission/low disease activity after discontinuation of induction or maintenance treatment with tumor necrosis factor inhibitors in rheumatoid arthritis: a systematic and scoping review
by: Michael M. Ward, et al.
Published: (2023-11-01)

Can Incobotulinumtoxin-A Treatment Improve Quality of Life Better Than Conventional Therapy in Spastic Muscle Post-Stroke Patients? Results from a Pilot Study from a Single Center
by: Adina Turcu-Stiolica, et al.
Published: (2021-07-01)

Induction of sustained remission in early inflammatory arthritis with the combination of infliximab plus methotrexate: the DINORA trial
by: Tanja Alexandra Stamm, et al.
Published: (2018-08-01)

Evaluation of the clinical efficiency of tocilizumab therapy, by using DAS 28, SDAI, CDAI indices and new 2011 EULAR/ACR remission criteria in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-04-01)

Wangbi granule as a combination therapy to achieve clinical deep remission in rheumatoid arthritis: protocol for a multicenter, triple-blind, randomised, placebo-controlled trial
by: Jinping Wang, et al.
Published: (2023-02-01)

Association between rapid and sustained remission and clinician- and patient-reported outcomes in patients with rheumatoid arthritis: post hoc analysis of data from the SELECT-COMPARE study
by: Laure Gossec, et al.
Published: (2025-06-01)

Factors Associated with Persistent Metatarsal Pain in Patients with Rheumatoid Arthritis in Remission: Clinical Implications and Multivariable Analysis in a Cross-Sectional Study
by: Rebeca Bueno Fermoso, et al.
Published: (2025-08-01)

LONG-TERM OUTCOMES IN RHEUMATOID ARTHRITIS IN RELATION TO THE TIME AFTER THE INITIATIONOF BASIC ANTI-INFLAMMATORY DRUG THERAPY
by: Natalya Vladimirovna Chichasova, et al.
Published: (2010-06-01)

The Clinical Value of Autoantibodies in Rheumatoid Arthritis
by: Serena Bugatti, et al.
Published: (2018-12-01)

Impact of sustained remission on quality of life among women with rheumatoid arthritis and systemic lupus erythematosus: a prospective observational study
by: Basant Elnady, et al.
Published: (2021-06-01)

The Role of Musculoskeletal Ultrasound in Biologic Drug Tapering and Relapse Monitoring: Findings from a One-Year Prospective Study in a Cohort of Rheumatoid Arthritis Patients in Sustained Clinical Remission
by: Zguro Batalov, et al.
Published: (2025-07-01)

Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biology
by: Xavier M Teitsma, et al.
Published: (2018-10-01)

PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS: RUSSIAN AND INTERNATIONAL GUIDELINES
by: E. L. Nasonov
Published: (2016-12-01)

The trajectory of clinical responses in patients with early rheumatoid arthritis who achieve sustained remission in response to abatacept: subanalysis of AVERT-2, a randomized phase IIIb study
by: Paul Emery, et al.
Published: (2023-04-01)

Application of superb microvascular imaging technology in diagnosing rheumatoid arthritis in the clinical remission stage
by: DIAO Xuehong, SHEN Yan, CHEN Lin, ZHAN Jia, FANG Liang, CAI Jianfei, CHEN Yue
Published: (2022-10-01)

Predictors of Boolean2.0 remission in rheumatoid arthritis identified using smart disease management system data
by: Yuqi Zhang, et al.
Published: (2025-04-01)